Most recently, it's been discovered that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to the big range of endogenous opioids. Contrary to most opioid receptors, this receptor functions like a scavenger https://warrena765fgd2.blogdeazar.com/profile